IRS 19 nasal spray 20ml

IRS 19 Pharmacodynamics:

IRS 19 increases specific and non-specific immunity. When spraying IRS 19, a fine aerosol is formed that covers the nasal mucosa, which leads to the rapid development of a local immune response. Specific protection is due to locally formed antibodies of the class of secretory immunoglobulins type A (IgA), which prevent the fixation and reproduction of infectious agents on the mucosa. Nonspecific immunoprotection is manifested in an increase in the phagocytic activity of macrophages and an increase in the content of lysozyme.

Pharmacotherapeutic group:  Immunostimulating drug based on bacterial lysates.

Indications:

infectious and inflammatory diseases of the ENT organs:  Runny nose;  Pharyngitis;  Laryngitis;  Tonsillitis;  Bronchitis; Otitis; Sinusitis.

Dosage:

In acute diseases, 2-4 injections in each nostril per day until the symptoms of the disease disappear (8-10 days). In chronic diseases and prevention, 2 injections per day in each nostril are sufficient for 4 weeks.

Shelf life:

3 years. From the moment of the first use – 8 weeks.